BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Growth in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a significant growth in short interest in August. As of August 15th, there was short interest totalling 2,100 shares, a growth of 950.0% from the July 31st total of 200 shares. Based on an average daily volume of 117,200 shares, the short-interest ratio is presently 0.0 days.

BriaCell Therapeutics Price Performance

NASDAQ BCTXW traded up $0.06 on Tuesday, hitting $0.41. 502 shares of the company traded hands, compared to its average volume of 64,446. The business’s 50 day moving average price is $0.22 and its 200-day moving average price is $0.76. BriaCell Therapeutics has a 52-week low of $0.11 and a 52-week high of $2.85.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.